Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GESTODENE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 117 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ferreira, ACP; Montes, MBA; Franceschini, SA; Toloi, MRT
      Effects of two oral contraceptives, containing 30 or 20 mu g of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    2. Lello, S; Monterubbianesi, M; Guardianelli, F; Bianchi, C; Simonelli, C
      Clinical trial of a monophasic estroprogestin oral formulation containing 20 mu g ethinyl estradiol and 75 mu g gestodene

      GYNECOLOGICAL ENDOCRINOLOGY
    3. Boggio, JC; Encinas, T; Rodrigue, C; Valtorta, SE; Rodriguez, JMR; San Andres, MI
      Rhythmic variations of pharmacokinetic processes of cyproterone acetate inrabbits

      BIOLOGICAL RHYTHM RESEARCH
    4. Bebawy, LI; Mostafa, AA; Refaat, HH
      Different methods for the determination of gestodene, and cyproterone acetate in raw material and dosage forms

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    5. Okon, MA; Lee, S; Laird, SM; Li, TC
      A prospective randomized controlled study comparing two doses of gestodenein cyclic combined HRT preparations on endometrial physiology

      HUMAN REPRODUCTION
    6. Klinger, G; Piater, T; Jager, R; Kuntzel, B; Schon, R; Hobe, G
      Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat (R) and Valette (R)

      PHARMAZIE
    7. Laine, K; Anttila, M; Nyman, L; Wahlberg, A; Bertilsson, L
      CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    8. Zimmermann, H; Maibauer, R; Schutt, B; Benda, N; Kaufmann, G; Pidun, A
      Bioequivalence of dienogest as a single component and dienogest in combination with estradiol valerate after single administration to healthy postmenopausal women

      DRUGS OF TODAY
    9. Poindexter, A
      The emerging use of the 20-mu g oral contraceptive

      FERTILITY AND STERILITY
    10. Lemus, AE; Santillan, R; Damian-Matsumura, P; Garcia, GA; Grillasca, I; Perez-Palacios, G
      In vitro metabolism of gestodene in target organs: formation of A-ring reduced derivatives with oestrogenic activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. De Leo, V; la Marca, A; Morgante, G; Lucani, B; Nami, R; Ciotta, L; Cianci, A; Petraglia, F
      Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives

      CONTRACEPTION
    12. Endrikat, J; Cronin, M; Gerlinger, C; Ruebig, A; Schmidt, W; Dusterberg, B
      Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 mu g ethinyl estradiol and 75 mu g gestodene and a 21-day regimen with 20 mu g ethinyl estradiol and 150 mu g desogestrel

      CONTRACEPTION
    13. Endrikat, J; Cronin, M; Gerlinger, C; Ruebig, A; Schmidt, W; Dusterberg, B
      Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 mu g ethinyl estradiol and 75 mu g gestodene

      CONTRACEPTION
    14. Hennessy, S; Berlin, JA; Kinman, JL; Margolis, DJ; Marcus, SM; Strom, BL
      Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis

      CONTRACEPTION
    15. Fruzzetti, F; Genazzani, AR; Ricci, C; De Negri, F; Bersi, C; Carmassi, F
      A 12-month clinical investigation with a 24-day regimen containing 15 mu gethinylestradiol plus 60 mu g gestodene with respect to hemostasis and cycle control

      CONTRACEPTION
    16. Deckers, GH; Schoonen, WGEJ; Kloosterboer, HJ
      Influence of the substitution of 11-methylene, Delta(15), and/or 18-methylgroups in norethisterone on receptor binding, transactivation assays and biological activities in animals

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    17. Bruni, V; Croxatto, H; De la Cruz, J; Dhont, M; Durlot, F; Fernands, MTMS; Andrade, RP; Weisberg, E; Rhoa, M
      A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives

      GYNECOLOGICAL ENDOCRINOLOGY
    18. Kluft, C
      Effects on haemostasis variables by second and third generation combined oral contraceptives: A review of directly comparative studies

      CURRENT MEDICINAL CHEMISTRY
    19. Middeldorp, S; Meijers, JCM; van den Ende, AE; van Enk, A; Bouma, BN; Tans, G; Rosing, J; Prins, MH; Buller, HR
      Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study

      THROMBOSIS AND HAEMOSTASIS
    20. Palovaara, S; Kivisto, KT; Tapanainen, P; Manninen, P; Neuvonen, PJ; Laine, K
      Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1 '-hydroxylation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    21. Bassol, S; Alvarado, A; Celis, C; Cravioto, MC; Peralta, O; Montano, R; Novelli, J; Albornoz, H; Kesseru, E; Soares, A; Petracco, A; Isaia, B; Mendes, J; Bahamondes, L; de Melo, NR; Reyes-Marquez, R; Albrecht, G
      Latin American experience with two low-dose oral contraceptives containing30 mu g ethinylestradiol/75 mu g gestodene and 20 mu g ethinylestradiol/150 mu g desogestrel

      CONTRACEPTION
    22. Winkler, UH
      Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism

      CONTRACEPTION
    23. Lawrenson, R; Farmer, R
      Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?

      CONTRACEPTION
    24. Paoletti, AM; Orru, M; Floris, S; Mannias, M; Vacca, AMB; Ajossa, S; Guerriero, S; Melis, GB
      Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women

      CONTRACEPTION
    25. Nevado, JJB; Flores, JR; Penalvo, GC
      Voltammetric behavior of gestodene using square-wave technique. Determination in oral contraceptives

      ELECTROANALYSIS
    26. Laine, K; Anttila, M; Helminen, A; Karnani, H; Huupponen, R
      Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    27. Berzas, JJ; Del Castillo, B; Castaneda, G; Pinilla, MJ
      Micellar electrokinetic capillary chromatography as an alternative method for the determination of ethinylestradiol and levo-norgestrel

      TALANTA
    28. Zimmermann, H; Duvauchelle, T; Gualano, V; Kaufmann, G; Bervoas-Martin, S; Breitbarth, H; Mathieu, M; Mellinger, U; Ntsikoussalabongui, B; Oettel, M; Thebault, JJ
      Pharmacokinetics of dienogest as a single drug or in combination with estradiol valerate or ethinylestradiol

      DRUGS OF TODAY
    29. Fitzgerald, C; Elstein, M; Spona, J
      Effect of age on the response of the hypothalamo-pituitary-ovarian axis toa combined oral contraceptive

      FERTILITY AND STERILITY
    30. Endrikat, J; Dusterberg, B; Ruebig, A; Gerlinger, C; Strowitzki, T
      Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

      CONTRACEPTION
    31. Laine, K; Palovaara, S; Tapanainen, P; Manninen, P
      Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    32. Berzas, JJ; Rodriguez, J; Castaneda, G; Pinilla, MJ
      Determination of ethinylestradiol and gestodene in oral contraceptives by micellar electrokinetic chromatography

      CHROMATOGRAPHIA
    33. Berzas, JJ; Castaneda, G; Pinilla, MJ
      Micellar electrokinetic capillary chromatography as an alternative method for the determination of estrogens

      ANALYTICAL LETTERS
    34. Archer, DF; Mammen, EF; Grubb, GS
      The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    35. Weiss, G
      Risk of venous thromboembolism with third-generation oral contraceptives: A review

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    36. ARCHER DF; GAST MJ
      AN INVESTIGATION OF OVULATION INHIBITION WITH A LOW-DOSE COMBINED ORAL-CONTRACEPTIVE CONTAINING 75 MU-G GESTODENE AND 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    37. VANHUESDEN AM; FAUSER BCJM; SPIELMAN D
      A COMPARATIVE CLINICAL INVESTIGATION OF ENDOCRINE PARAMETERS WITH 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150MU-G DESOGESTREL COMBINED WITH 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    38. BLOEMENKAMP KWM; HELMERHORST FM; DERSJANTROORDA MD; DEBOER R; MEYER P; SPIELMANN D; KLUFT C
      A COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150 MU-G DESOGESTREL COMBINEDWITH 20 MU-G ETHINYLESTRADIOL - EFFECT ON HEMOSTASIS, LIPID-METABOLISM AND CARBOHYDRATE-METABOLISM

      Gynecological endocrinology
    39. GAST MJ; GRUBB G
      A REVIEW OF CYCLE CONTROL WITH A LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 75 MU-G GESTODENE AND 20 MU-G ETHINYLESTRADIOL

      Gynecological endocrinology
    40. HOFFMANN H; MOORE C; ZIMMERMANN H; ELGER W; SCHWARZ S; GRASER T; OETTEL M
      APPROACHES TO THE REPLACEMENT OF ETHINYLESTRADIOL BY NATURAL 17-BETA-ESTRADIOL IN COMBINED ORAL-CONTRACEPTIVES

      Experimental and toxicologic pathology
    41. LIPP R; LAURENT H; GUNTHER C; RIEDL J; ESPERLING P; TAUBER U
      PRODRUGS OF GESTODENE FOR MATRIX-TYPE TRANSDERMAL DRUG-DELIVERY SYSTEMS

      Pharmaceutical research
    42. COMPARATO MR; YABUR JA; BAJARES M
      CONTRACEPTIVE EFFICACY AND ACCEPTABILITY OF A MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING 30 MU-G ETHINYL ESTRADIOL AND 150 MU-G DESOGESTREL IN LATIN-AMERICAN WOMEN

      Advances in contraception
    43. KUHNZ W; GIESCHEN H
      PREDICTING THE ORAL BIOAVAILABILITY OF 19-NORTESTOSTERONE PROGESTINS IN-VIVO FROM THEIR METABOLIC STABILITY IN HUMAN LIVER MICROSOMAL PREPARATIONS IN-VITRO

      Drug metabolism and disposition
    44. BOGGIO JC; ENCINAS T; RODRIGUEZ C; VINAGRE E; SANANDRES MD; SANANDRES MI
      CHRONOPHARMACOKINETIC BEHAVIOR OF CYPROTERONE-ACETATE IN RABBITS

      Research in Veterinary Science
    45. LUKKARI E; HAKONEN T; NEUVONEN PJ
      THE PHARMACOKINETICS OF OXYBUTYNIN IS UNAFFECTED BY GENDER AND CONTRACEPTIVE STEROIDS

      European Journal of Clinical Pharmacology
    46. Balogh, A; Gessinger, S; Svarovsky, U; Hippius, M; Mellinger, U; Klinger, G; Hoffmann, A; Oettel, M
      Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    47. CZEKAJ P; NOWACZYKDURA G; CISZKOWA V
      EFFECTS OF ETHINYLESTRADIOL NORETHISTERONE ACETATE COMBINATIONS ON THE ULTRASTRUCTURE OF LIVER, KIDNEY, OVARY AND ENDOMETRIUM CELLS

      Folia biologica
    48. CARR BR
      UNIQUENESS OF ORAL-CONTRACEPTIVE PROGESTINS

      Contraception
    49. REDMOND GP
      EFFECTIVENESS OF ORAL-CONTRACEPTIVES IN THE TREATMENT OF ACNE

      Contraception
    50. ADEN U; JUNGHOFFMANN C; KUHL H
      A RANDOMIZED CROSS-OVER STUDY ON VARIOUS HORMONAL PARAMETERS OF 2 TRIPHASIC ORAL-CONTRACEPTIVES

      Contraception
    51. WIEGRATZ I; JUNGHOFFMANN C; GROSS W; KUHL H
      EFFECT OF 2 ORAL-CONTRACEPTIVES CONTAINING ETHINYL ESTRADIOL AND GESTODENE OR NORGESTIMATE ON DIFFERENT LIPID AND LIPOPROTEIN PARAMETERS

      Contraception
    52. FARMER RDT; LAWRENSON RA
      ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLIC DISEASE - THE FINDINGS FROM DATABASE STUDIES IN THE UNITED-KINGDOM AND GERMANY

      American journal of obstetrics and gynecology
    53. GALLICANO K; MCGILVERAY I
      ANALYTICAL METHODS FOR MEASUREMENT OF CONTRACEPTIVE STEROIDS IN HUMANPLASMA

      Journal of clinical ligand assay
    54. KIM BR; OH HS; KIM DH
      DIFFERENTIAL INHIBITION OF AFLATOXIN B-1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER-MICROSOMES

      Biochemistry and molecular biology international
    55. AMICHAI B; LAZAROV A
      ERUPTIVE PSEUDOANGIOMATOSIS INDUCED BY GESTODENE IN AN ORAL-CONTRACEPTIVE

      JEADV. Journal of the European Academy of Dermatology and Venereology
    56. BERZAS JJ; RODRIGUEZ J; GASTANEDA G
      DETERMINATION OF ETHINYLESTRADIOL AND GESTODENE IN PHARMACEUTICALS BYA PARTIAL LEAST-SQUARES AND PRINCIPAL COMPONENT REGRESSION MULTIVARIATE CALIBRATION

      Analytical sciences
    57. LEVESQUE H; BORG JY; COURTOIS H
      THE VASCULAR RISK OF 3RD-GENERATION ORAL- CONTRACEPTIVES

      Journal des maladies vasculaires
    58. MILLS A
      COMBINED ORAL CONTRACEPTION AND THE RISK OF VENOUS THROMBOEMBOLISM

      Human reproduction
    59. LEWIS MA; HEINEMANN LAJ; SPITZER WO; MACRAE KD; BRUPPACHER R
      THE USE OF ORAL-CONTRACEPTIVES AND THE OCCURRENCE OF ACUTE MYOCARDIAL-INFARCTION IN YOUNG-WOMEN - RESULTS FROM THE TRANSNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND THE HEALTH OF YOUNG-WOMEN

      Contraception
    60. SPONA J; FEICHTINGER W; KINDERMANN C; SCHNEIDER B; MELLINGER U; WALTER F; MOORE C; GRASER T
      DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY ON THE EFFECTS OF THE MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING 30 MU-G ETHINYL ESTRADIOLAND 2.00 MG DIENOGEST ON THE HEMOSTATIC SYSTEM

      Contraception
    61. ROSSMANITH WG; STEFFENS D; SCHRAMM G
      A COMPARATIVE RANDOMIZED TRIAL ON THE IMPACT OF 2 LOW-DOSE ORAL-CONTRACEPTIVES ON OVARIAN ACTIVITY, CERVICAL PERMEABILITY, AND ENDOMETRIAL RECEPTIVITY

      Contraception
    62. STANCZYK FZ
      PHARMACOKINETICS OF THE NEW PROGESTOGENS AND INFLUENCE OF GESTODENE AND DESOGESTREL ON ETHINYLESTRADIOL METABOLISM

      Contraception
    63. ENDRIKAT J; MULLER U; DUSTERBERG B
      A 12-MONTH COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING 20-MU-G ETHINYLESTRADIOL 75-MU-G GESTODENE AND 30-MU-G ETHINYLESTRADIOL 75-MU-G GESTODENE, WITH RESPECT TO EFFICACY, CYCLE CONTROL, AND TOLERANCE

      Contraception
    64. NEVADO JJB; FLORES JR; PENALVO GC; BERNARDO FJG
      SIMULTANEOUS DETERMINATION OF ETHINYLESTRADIOL AND GESTODENE IN ORAL-CONTRACEPTIVES BY DERIVATIVE SPECTROPHOTOMETRY

      Analytical letters
    65. VANDENBROUCKE JP; HELMERHORST FM; BLOEMENKAMP KWM; ROSENDAAL FR
      3RD-GENERATION ORAL-CONTRACEPTIVE AND DEEP VENOUS THROMBOSIS - FROM EPIDEMIOLOGIC CONTROVERSY TO NEW INSIGHT IN COAGULATION

      American journal of obstetrics and gynecology
    66. WINKLER UH; HOLSCHER T; SCHULTE H; ZIERLEYN JP; COLLET W; SCHINDLER AE
      ETHINYLESTRADIOL-20 VERSUS 30-MU-G COMBINED WITH 150-MU-G DESOGESTREL- A LARGE COMPARATIVE-STUDY OF THE EFFECTS OF 2 LOW-DOSE ORAL-CONTRACEPTIVES ON THE HEMOSTATIC SYSTEM

      Gynecological endocrinology
    67. DUSTERBERG B; ELLMAN H; MULLER U; ROWE E; MUHE B
      A 3-YEAR CLINICAL INVESTIGATION INTO EFFICACY, CYCLE CONTROL AND TOLERABILITY OF A NEW LOW-DOSE MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING GESTODENE

      Gynecological endocrinology
    68. NORRIS LA; BONNAR J
      THE EFFECT OF ESTROGEN DOSE AND PROGESTOGEN TYPE ON HEMOSTATIC CHANGES IN WOMEN TAKING LOW-DOSE ORAL-CONTRACEPTIVES

      British journal of obstetrics and gynaecology
    69. KUHNZ W; HUMPEL M; BIERE H; GROSS D
      INFLUENCE OF REPEATED ORAL DOSES OF ETHINYLESTRADIOL ON THE METABOLICDISPOSITION OF [C-13(2)]-ETHINYLESTRADIOL IN YOUNG-WOMEN

      European Journal of Clinical Pharmacology
    70. GENTILE DM; TOMLINSON ES; MAGGS JL; PARK BK; BACK DJ
      DEXAMETHASONE METABOLISM BY HUMAN LIVER IN-VITRO - METABOLITE IDENTIFICATION AND INHIBITION OF 6-HYDROXYLATION

      The Journal of pharmacology and experimental therapeutics
    71. SPEROFF L
      ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM

      International journal of gynaecology and obstetrics
    72. BRILL K; THEN A; BEISIEGEL U; JENE A; WUNSCH C; LEIDENBERGER F
      INVESTIGATION OF THE INFLUENCE OF 2 LOW-DOSE MONOPHASIC ORAL-CONTRACEPTIVES CONTAINING 20 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE AND 30 MU-G ETHINYLESTRADIOL 75 MU-G GESTODENE, ON LIPID-METABOLISM IN AN OPEN RANDOMIZED TRIAL

      Contraception
    73. SPONA J; ELSTEIN M; FEICHTINGER W; SULLIVAN H; LUDICKE F; MULLER U; DUSTERBERG B
      SHORTER PILL-FREE INTERVAL IN COMBINED ORAL-CONTRACEPTIVES DECREASES FOLLICULAR DEVELOPMENT

      Contraception
    74. MANGO D; RICCI S; MANNA P; MIGGIANO GAD; SERRA GB
      CLINICAL AND HORMONAL EFFECTS OF ETHINYLESTRADIOL COMBINED WITH GESTODENE AND DESOGESTREL IN YOUNG-WOMEN WITH ACNE-VULGARIS

      Contraception
    75. WINKLER UH; SCHINDLER AE; ENDRIKAT J; DUSTERBERG B
      A COMPARATIVE-STUDY OF THE EFFECTS OF THE HEMOSTATIC SYSTEM OF 2 MONOPHASIC GESTODENE ORAL-CONTRACEPTIVES CONTAINING 20 MU-G AND 30 MU-G ETHINYLESTRADIOL

      Contraception
    76. ROSENBERG MJ; WAUGH MS; HIGGINS JE
      THE EFFECT OF DESOGESTREL, GESTODENE, AND OTHER FACTORS ON SPOTTING AND BLEEDING

      Contraception
    77. NEWTON JR
      CLASSIFICATION AND COMPARISON OF ORAL-CONTRACEPTIVES CONTAINING NEW-GENERATION PROGESTOGENS

      Human reproduction update
    78. QUEREUX C
      ESTROPROGESTATIVE CONTRACEPTION

      Contraception fertilite sexualite
    79. WINKLER UH; OBERHOFF C; BIER U; SCHINDLER AE; GILLAIN D
      HEMOSTATIC EFFECTS OF 2 ORAL-CONTRACEPTIVES CONTAINING LOW-DOSES OF ETHINYL ESTRADIOL AND EITHER GESTODENE OR NORGESTIMATE - AN OPEN, RANDOMIZED, PARALLEL-GROUP STUDY

      International journal of fertility and menopausal studies
    80. KUHNZ W; LOFBERG B
      URINARY-EXCRETION OF 6-BETA-HYDROXYCORTISOL IN WOMEN DURING TREATMENTWITH DIFFERENT ORAL-CONTRACEPTIVE FORMULATIONS

      Journal of steroid biochemistry and molecular biology
    81. TEICHMANN AT; BRILL K; ALBRING M; SCHNITKER J; WOJTYNEK P; KUSTRA E
      THE INFLUENCE OF THE DOSE OF ETHINYLESTRADIOL IN ORAL-CONTRACEPTIVES ON FOLLICLE GROWTH

      Gynecological endocrinology
    82. FURNISS H; SULLIVAN H; FITZGERALD C; ELSTEIN M
      LOW-DOSE COMBINED ORAL-CONTRACEPTIVES

      British journal of obstetrics and gynaecology
    83. KIRSCHBAUM C; PIRKE KM; HELLHAMMER DH
      PRELIMINARY EVIDENCE FOR REDUCED CORTISOL RESPONSIVITY TO PSYCHOLOGICAL STRESS IN WOMEN USING ORAL-CONTRACEPTIVE MEDICATION

      Psychoneuroendocrinology
    84. KUHL H; JUNGHOFFMANN C; FITZNER M; MARZ W; GROSS W
      SHORT-TERM AND LONG-TERM EFFECTS ON LIPID-METABOLISM OF ORAL-CONTRACEPTIVES CONTAINING 30 MU-G ETHINYLESTRADIOL AND 150 MU-G DESOGESTREL OR3-KETO-DESOGESTREL

      Hormone research
    85. KUHL H; JUNGHOFFMANN C; FITZNER M
      PRODRUG VERSUS DRUG EFFECTS OF 150 MU-G DESOGESTREL OR 3-KETO-DESOGESTREL IN COMBINATION WITH 30 MU-G ETHINYLESTRADIOL ON HORMONAL PARAMETERS - RELEVANCE OF THE PEAK SERUM LEVEL OF 3-KETO-DESOGESTREL

      Hormone research
    86. PETERSEN KR; SKOUBY SO; VEDEL P; HAABER AB
      HORMONAL CONTRACEPTION IN WOMEN WITH IDDM - INFLUENCE ON GLYCOMETABOLIC CONTROL AND LIPOPROTEIN METABOLISM

      Diabetes care
    87. BALOGH A; KLINGER G; HENSCHEL L; BORNER A; VOLLANTH R; KUHNZ W
      INFLUENCE OF ETHINYLESTRADIOL-CONTAINING COMBINATION ORAL-CONTRACEPTIVES WITH GESTODENE OR LEVONORGESTREL

      European Journal of Clinical Pharmacology
    88. MOORE LL; VALUCK R; MCDOUGALL C; FINK W
      A COMPARATIVE-STUDY OF ONE-YEAR WEIGHT-GAIN AMONG USERS OF MEDROXYPROGESTERONE ACETATE, LEVONORGESTREL IMPLANTS, AND ORAL-CONTRACEPTIVES

      Contraception
    89. ENDRIKAT J; JAQUES MA; MAYERHOFER M; PELISSIER C; MULLER U; DUSTERBERG B
      A 12-MONTH COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING 20-MU-G ETHINYLESTRADIOL 75-MU-G CESTODENE AND 20-MU-G ETHINYLESTRADIOL 75-MU-G DESOGESTREL, WITH RESPECT TO EFFICACY,CYCLE CONTROL AND TOLERANCE

      Contraception
    90. SINGH MM; FAHNRICH M; HASAN SH; ELGER W
      REVERSIBILITY OF ANTIGESTAGENIC ACTION OF ANTIPROGESTIN ONAPRISTONE BY EXOGENOUS PROGESTAGENS DURING EARLY-PREGNANCY IN GUINEA-PIG

      Contraception
    91. FUCHS N; DUSTERBERG B; WEBERDIEHL F; MUHE B
      THE EFFECT ON BLOOD-PRESSURE OF A MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING ETHINYLESTRADIOL AND GESTODENE

      Contraception
    92. WIEGRATZ I; JUNGHOFFMANN C; KUHL H
      EFFECT OF 2 ORAL-CONTRACEPTIVES CONTAINING ETHINYLESTRADIOL AND GESTODENE OR NORGESTIMATE UPON ANDROGEN PARAMETERS AND SERUM BINDING-PROTEINS

      Contraception
    93. KOETSAWANG S; CHAROENVISAL C; BANHARNSUPAWAT L; SINGHAKOVIN S; KAEWSUK O; PUNNAHITANONT S
      MULTICENTER TRIAL OF 2 MONOPHASIC ORAL-CONTRACEPTIVES CONTAINING 30 MCG ETHINYLESTRADIOL AND EITHER DESOGESTREL OR GESTODENE IN THAI WOMEN

      Contraception
    94. FOTHERBY K
      12 YEARS OF CLINICAL-EXPERIENCE WITH AN ORAL-CONTRACEPTIVE CONTAINING30-MU-G ETHINYLESTRADIOL AND 150-MU-G DESOGESTREL

      Contraception
    95. SCHLIT AF; GRANDJEAN P; DONNEZ J; LAVENNE E
      LARGE INCREASE IN PLASMATIC 11-DEHYDRO-TXB2 LEVELS DUE TO ORAL-CONTRACEPTIVES

      Contraception
    96. SAANO V; GLUE P; BANFIELD CR; REIDENBERG P; COLUCCI RD; MEEHAN JW; HARING P; RADWANSKI E; NOMEIR A; LIN CC; JENSEN PK; AFFRIME MB
      EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF A LOW-DOSE COMBINATION ORAL-CONTRACEPTIVE

      Clinical pharmacology and therapeutics
    97. KUHL H; JUNGHOFFMANN C; WIEGRATZ I
      GESTODENE-CONTAINING CONTRACEPTIVES

      Clinical obstetrics and gynecology
    98. DARNEY PD
      THE ANDROGENICITY OF PROGESTINS

      The American journal of medicine
    99. TACEY RL; HARMAN WJ; KELLY LL
      DEVELOPMENT OF A HIGHLY SENSITIVE AND SPECIFIC ASSAY FOR PLASMA ETHINYLESTRADIOL USING COMBINED EXTRACTION, LIQUID-CHROMATOGRAPHY AND RADIOIMMUNOASSAY

      Journal of pharmaceutical and biomedical analysis
    100. ROBINSON GE
      LOW-DOSE COMBINED ORAL-CONTRACEPTIVES

      British journal of obstetrics and gynaecology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 03:43:05